Chemoinformaics analysis of 15-HYDROXYPENTADECANOIC-ACID
| Molecular Weight | 258.402 | nRot | 14 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 1 |
| Exact Molecular Weight | 258.219 | nRing | 0 |
| Solubility: LogS | -3.382 | nHRing | 0 |
| Solubility: LogP | 4.467 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 47.4598 |
| nHD | 2 | BPOL | 30.9642 |
| QED | 0.46 |
| Synth | 1.764 |
| Natural Product Likeliness | 0.543 |
| NR-PPAR-gamma | 0.964 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.03 |
| Pgp-sub | 0.001 |
| HIA | 0.011 |
| CACO-2 | -5.241 |
| MDCK | 0.0000366 |
| BBB | 0.712 |
| PPB | 0.957057 |
| VDSS | 0.443 |
| FU | 0.0181291 |
| CYP1A2-inh | 0.095 |
| CYP1A2-sub | 0.171 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.148 |
| CYP2c9-sub | 0.982 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.057 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.02 |
| CL | 2.982 |
| T12 | 0.778 |
| hERG | 0.036 |
| Ames | 0.005 |
| ROA | 0.02 |
| SkinSen | 0.89 |
| Carcinogencity | 0.103 |
| EI | 0.982 |
| Respiratory | 0.324 |
| NR-Aromatase | 0.117 |
| Antiviral | Yes |
| Prediction | 0.752194 |